In the first-ever food-tech Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE), SavorEat (TASE: SVRT) has raised NIS 42.6 million (about $13 million) from leading Israeli institutional investors.
ChickP: The new chickpea starch can be used to thicken alternative dairy, as well as plant-based meat analogs, desserts, soups, and baked goods.
Dr. Itzik Goldwaser talks about his personal journey before becoming the head of Yissum. (Spanish)
GemmaCert a Yissum cannabis-tech spinout, has developed in-house testing solutions to test the active ingredients in cannabis by analyzing total THC and CBD levels throughout the entire supply chain.
Congratulations to Yissum spinouts Future Meat Technologies and SavorEat for making the finals in the FoodTech Innovation contest sponsored by Calcalist and Tnuva.
Startups from The Hebrew University of Jerusalem raised $79 million in the first half of 2020. Despite the continuing global uncertainty caused by the coronavirus and ongoing lockdowns around the world, 14 Yissum spinouts raised tens of millions...
SavorEat announced a $3M Series A funding round from Meitav Dash following a recent raise of $1.75M in seed funding from Millennium Food Tech. Their goal is to offer personalized burgers tailor-fitted to your preferred taste.
Better Juice teamed up with several U.S.-based global beverage companies to commercialize its sugar-reduction technology.
Yissum subsidiary, Betalin Therapeutics Ltd. has announced that it is ready to start human trials pending approval. It's "bio-artificial” pancreas aims to free patients of the need for insulin injections and blood sugar...
Nectin Therapeutics, a leading developer of next-generation immuno-oncology bio therapies, raised $6 million with the total expected to reach $15 million. The investment round was led by aMoon Velocity, the early-stage fund of VC aMoon Fund.
New treatment, which allows previously topical drug to be administered intravenously, is ‘a game-changer’ in the battle against antibiotic-resistant bacteria. It could have a significant impact on the morbidity rate for pandemics such as...
Researchers at The Hebrew University of Jerusalem as well as several Yissum start-up companies are exploring a variety of methods to combat the COVID-19 virus, through investigations into AI drug discovery, biochemical detection tools, and...